Publication:
Occult Hepatitis B Infection in End-Stage Renal Disease Patients Starting Maintenance Hemodialysis at a Tertiary Care Hospital: A Descriptive Cross-sectional Study

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorShrestha, Shailendra
dc.contributor.authorTiwari, Pratap Sagar
dc.contributor.authorPradhan, Bikram
dc.date.accessioned2026-03-12T04:46:08Z
dc.date.available2026-03-12T04:46:08Z
dc.date.issued2021
dc.descriptionShailendra Shrestha Department of Internal Medicine, Nobel Medical College Teaching Hospital, Biratnagar, Nepal Pratap Sagar Tiwari Department of Internal Medicine, Nobel Medical College Teaching Hospital, Biratnagar, Nepal Bikram Pradhan Department of Gastroenterology and Hepatology, BP Koirala Institute of Health Sciences, Dharan, Nepal
dc.description.abstractAbstract: Introduction: Occult hepatitis B infection is defined as the presence of the hepatitis B virus deoxyribonucleic acid in liver tissues and/or serum in the absence of serum hepatitis B Virus surface antigen. The prevalence of occult hepatitis B infection in end-stage renal disease patients is largely unknown. The aim of the study is to determine the prevalence of occult hepatitis B infection in the hemodialysis population starting maintenance hemodialysis. Methods: A descriptive cross-sectional study was conducted in the department of Internal Medicine of a tertiary care hospital. Convenience sampling method was used; 50 consecutive end-stage renal disease patients, who started maintenance hemodialysis from March 2019 to March 2020, were enrolled in the study. The study was approved by the Institutional Review Committee of the hospital (reference number: 351/2019). Statistical Package for Social Sciences version 26.0 was used for statistical analysis. Results: The mean age of the patients was 50.34±12.65 years, and 42 (84%) were male. About 4 (8%) patients were diagnosed having occult hepatitis B infection, 3 (6%) of them were seropositive and 1 (2%) seronegative. About 41 (82%) patients had no history of hepatitis B vaccination series before starting hemodialysis; 36 (72%) had anti-hepatitis B surface antibody titre <10 mIU/ml. About 44 (88%) patients received a blood transfusion during their hemodialysis sessions and 14 (28%) patients had a history of receiving hemodialysis at other centres. Conclusions: Our study demonstrated a high prevalence of occult hepatitis B infection among end-stage renal disease patients starting hemodialysis.
dc.identifierhttps://doi.org/10.31729/jnma.5723
dc.identifier.urihttps://hdl.handle.net/20.500.14572/5064
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectend-stage renal disease
dc.subjecthemodialysis
dc.subjecthepatitis B
dc.titleOccult Hepatitis B Infection in End-Stage Renal Disease Patients Starting Maintenance Hemodialysis at a Tertiary Care Hospital: A Descriptive Cross-sectional Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage341
oaire.citation.startPage336
relation.isJournalIssueOfPublicationce2b61bd-10a3-4745-9c02-93f58d899e92
relation.isJournalIssueOfPublication.latestForDiscoveryce2b61bd-10a3-4745-9c02-93f58d899e92
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
336-341.pdf
Size:
398.72 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections